BioSyntech's BST-CarGel to be Highlighted in Montreal Press Conference.Business Editors/Health/Medical Writers LAVAL, Quebec--(BUSINESS WIRE)--Oct. 3, 2003 The regeneration of articular cartilage articular cartilage n. The cartilage covering the articular surfaces of the bones forming a synovial joint. Also called arthrodial cartilage, diarthrodial cartilage, investing cartilage. is the mechanism behind Biosyntech's BST-CarGel(TM), which represents a major advancement in the field of regenerative medicine. Biosyntech announced today that a press conference will be held at the Montreal Marriott Chateau Champlain on Tuesday, October 21, at 10 a.m., wherein the company will discuss their technology, the product, and its orthopedic use. To date, 3 patients in Canada have undergone clinical BST-CarGel treatment in the knee. Although possessing damaged cartilage of varying severities, all 3 men have experienced complete recoveries and are in the midst Adv. 1. in the midst - the middle or central part or point; "in the midst of the forest"; "could he walk out in the midst of his piece?" midmost of customized physiotherapy programs. About BioSyntech - BioSyntech Inc. is an ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9001:2000 certified, advanced biomaterials company specializing in tissue repair and in the delivery of therapeutic products. The Company's patented platform technology BST-Gel(R), is a multifunctional injectable thermo-sensitive and self-forming hydrogel hy·dro·gel n. A colloidal gel in which the particles are dispersed in water. hydrogel a gel that contains water. hydrogel Wound care A polymer absorptive wound dressing. See Dressing. that can be used for tissue repair or for targeted delivery of therapeutic agents. These biomaterials are biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function. , biodegradable, muco-adhesive and provide significant advantages in specialized medical fields including, Tissue Engineering Orthopaedics, Reconstructive Surgery Oncology, Rheumatology rheumatology /rheu·ma·tol·o·gy/ (-tol´ah-je) the branch of medicine dealing with rheumatic disorders, their causes, pathology, diagnosis, treatment, etc. rheu·ma·tol·o·gy n. , Vaccines and many other therapeutic areas. For additional information, visit www.biosyntech.com. This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors are detailed from time to time in the company's filings with the regulatory authorities having jurisdiction. No regulatory authority has approved or disapproved the content of this release. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion